Novel susceptibility genes associated with diabetic cataract in a Taiwanese population

Ophthalmic Genetics

Volumn 34, Issue 1-2, 2013, Pages 35-42

  Lin, Hui Ju ^a,b   Huang, Yu Chuen ^a,b   Lin, Jane Ming ^a,b   Liao, Wen Ling ^a   Wu, Jer Yuarn ^c   Chen, Chien Hsiun ^b,e   Chou, Yi Chun ^e   Chen, Liuh An ^a   Lin, Chao Jen ^d   Tsai, Fuu Jen ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cataract; Diabetic; Genome wide association study; Haplotype; Linkage disequilibrium

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ALLELE; ARTICLE; CATARACT; CHROMOSOME 4; CHROMOSOME 7; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; CATARACT; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TAIWAN;

EID: 84876029709     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2012.736590     Document Type: Article

References (40)

1. Javitt JC, Wang F, West SK. Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health 1996;17:159-177.
2. Benjamin CL, Karan RA. How to help prevent cataract: a review of the role of environment, antioxidants, carotenoids, nutrition, enzymes, diet, medications, metabolism and other factors on cataract. Rev Optom 2010;147:55-65.
3. Richter L, Flodman P, Barria von-Bischhoffshausen F, et al. Clinical variability of autosomal dominant cataract, microcornea and corneal opacity and novel mutation in the alpha A crystallin gene (CRYAA). Am J Med Genet 2008;146:833-842.
4. Shiels A, Hejtmancik JF. Genetic origins of cataract. Arch Ophthalmol 2007;125:165-173.
5. Qi YH, Jia HY, Huang SZ, et al. Autosomal dominant congenital nuclear cataract caused by a deletion mutation in the beta A1-crystallin gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003;20:486-489.
6. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787.
7. Zhou Z, Wang B, Hu S, Zhang C, Ma X, Qi Y. Genetic variations in GJA3, GJA8, LIM2, and age-related cataract in the Chinese population: a mutation screening study. Mol Vis 2011;17:621-626.
8. Maraini G, Pasquini P, Sperduto RD, et al. The effect of cataract severity and morphology on the reliability of the Lens Opacities Classification System II (LOCS II). Invest Ophthalmol Vis Sci 1991;32:2400-2403.
9. Pan WH, Fann CS, Wu JY, et al. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 2006;61:27-30.
10. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
11. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40:1092-1097.
12. Marx N, Schbeck U, Lazar MA, Libby P, Plutzky J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 1998;83:1097-1103.
13. Perry JR, Frayling TM. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 2008;11:371-377.
14. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-885.
15. Tsai FJ, Yang CF, Chen CC, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet 2010;6:e1000847.
16. Lin HJ, Huang YC, Lin JM, et al. Single-nucleotide polymorphisms in chromosome 3p14.1- 3p14.2 are associated with susceptibility of Type 2 diabetes with cataract. Mol Vis 2010;16:1206-1214.
17. Law SF, Zhang YZ, Fashena SJ, Toby G, Estojak J, Golemis EA. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. Exp Cell Res 1999;252:224-235.
18. Singh M, Cowell L, Seo S, O'Neill G, Golemis E. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochem Biophys 2007;48:54-72.
19. Tikhmyanova N, Golemis EA. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation. PLoS One 2011;6:e22102.
20. Ramialison M, Bajoghli B, Aghaallaei N, et al. Rapid identification of PAX2/5/8 direct downstream targets in the otic vesicle by combinatorial use of bioinformatics tools. Genome Biol 2008;9:R145.
21. Jakobs PM, Hess JF, FitzGerald PG, Kramer P, Weleber RG, Litt M. Autosomal-dominant congenital cataract associated with a deletion mutation in the human beaded filament protein gene BFSP2. Am J Hum Genet 2000;66:1432-1436.
22. Kitazawa M, Nagano M, Masumoto KH, Shigeyoshi Y, Natsume T, Hashimoto S. Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes. Endocrinology 2011;152:2558-2567.
23. Fernandez-Madrid F, Tang N, Alansari H, et al. Autoantibodies to annexin XI-A and other autoantigens in the diagnosis of breast cancer. Cancer Res 2004;64:5089-5096.
24. Dekker N, Voorn-Brouwer T, Verhoek M, et al. The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation. Blood Cells Mol Dis 2011;46:19-26.
25. Beutler E, Beutler L, West C. Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease. J Lab Clin Med 2004;144:65-68.
26. Kouidhi S, Jarboui S, Marrakchi R, et al. Adiponectin expression and metabolic markers in obesity and type 2 diabetes. J Endocrinol Invest 2011;34:e16-23.
27. Chatterjee PK. Hepatic inflammation and insulin resistance in pre-diabetes - further evidence for the beneficial actions of PPAR-gamma agonists and a role for SOCS-3 modulation. Br J Pharmacol 2010;160:1889-1891.
28. Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol 2007;595:127-148
29. Hogart A, Nagarajan RP, Patzel KA, Yasui DH, Lasalle JM. 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum Mol Genet 2007;16:691-703.
30. Kardos J, PallA, Bencsura A, Simon A. Assessing structure, function and druggability of major inhibitory neurotransmitter gamma-aminobutyrate symporter subtypes. Curr Med Chem 2010;17:2203-2213.
31. Bignone PA, Lee KY, Liu Y, et al. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene 2007;26:683-700.
32. Pancholi S, Lykkesfeldt AE, Hilmi C, et al. ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen- resistant MCF-7 cells leading to the activation of AKT and RPS6KA2. Endocr Relat Cancer 2008;15:985-1002.
33. Narberhaus F. Alpha-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network. Microbiol Mol Biol Rev 2002;66:64-93.
34. Oksala NK, Laaksonen DE, Lappalainen J, et al. Heat shock protein 60 response to exercise in diabetes. Effects of α-lipoic acid supplementation. J Diabetes Complications 2006;20:257-261.
35. Shanley L, Lear M, Davidson S, Ross R, MacKenzie A. Evidence for regulatory diversity and auto-regulation at the TAC1 locus in sensory neurones. J Neuroinflammation 2011;8:10.
36. Karagiannides I, Bakirtzi K, Kokkotou E, et al. Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways. Endocrinology 2011;152:4571-4580.
37. Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol Med 2010;16:247-253.
38. Okano Y, Asada M, Fujimoto A, et al. A genetic factor for age-related cataract: identification and characterization of a novel galactokinase variant, "Osaka," in Asians. Am J Hum Genet 2001;68:1036-1042.
39. Jun G, Guo H, Klein BE, et al. EPHA2 is associated with agerelated cortical cataract in mice and humans. PLoS Genet. 2009;5:e1000584.
40. Pan WH, Fann CS, Wu JY, et al. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 2006; 61:27-30.